Association study of polymorphisms in N-methyl-D-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism

被引:33
作者
Kim, Jin Hee
Park, Mira
Yang, So Young
Jeong, Bum Seok
Yoo, Hee Jeong
Kim, Jong-Woo
Chung, Joo-Ho
Kim, Soon Ae
机构
[1] Eulji Univ, Sch Med, Dept Pharmacol, Taejon 301832, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
alcoholism; N-methyl-D-aspartate (NMDA) receptor 2B gene (NR2B; GRIN2B); polymorphism; haplotype; association;
D O I
10.1016/j.neures.2006.06.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The N-methyl-D-aspartate (NMDA) receptor 2B gene (GRIN2B) was studied as a candidate gene of alcoholism. This study aimed to investigate the association between each of the three GRIN2B polymorphisms (rs1806201, rs1805247, and rs1805502) and alcoholism. This study included 206 alcoholic patients and 189 unrelated control subjects of Korean origin. Associations between genotype, allele, and haplotype frequencies of the polymorphisms and alcoholism were investigated. The genotype frequencies of rs1806201 and the haplotype analysis of SNPs in this study show significantly differences between the case and controls. These findings suggest new candidate SNPs in GRIN2B for studying the genetic susceptibility to alcoholism. (c) 2006 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:220 / 223
页数:4
相关论文
共 16 条
[1]   Glutamate-mediated transmission, alcohol, and alcoholism [J].
Dodd, PR ;
Beckmann, AM ;
Davidson, MS ;
Wilce, PA .
NEUROCHEMISTRY INTERNATIONAL, 2000, 37 (5-6) :509-533
[2]  
Fink K, 1996, N-S ARCH PHARMACOL, V354, P312
[3]  
GULYA K, 1991, BRAIN RES, V547, P129
[4]   Long-term voluntary ethanol drinking increases expression of NMDA receptor 2B subunits in rat frontal cortex [J].
Henniger, MSH ;
Wotjak, CT ;
Hölter, SM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 470 (1-2) :33-36
[5]   Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients [J].
Krystal, JH ;
Petrakis, IL ;
Limoncelli, D ;
Webb, E ;
Gueorgueva, R ;
D'Souza, DC ;
Boutros, NN ;
Trevisan, L ;
Charney, DS .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (11) :2020-2028
[6]  
MASOOD K, 1994, MOL PHARMACOL, V45, P324
[7]   Implications of the NR2B subunit-containing NMDA receptor localized in mouse limbic forebrain in ethanol dependence [J].
Narita, M ;
Soma, M ;
Narita, M ;
Mizoguchi, H ;
Tseng, LF ;
Suzuki, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (02) :191-195
[8]   Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: Analysis of association with schizophrenia [J].
Nishiguchi, N ;
Shirakawa, O ;
Ono, H ;
Hashimoto, T ;
Maeda, K .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (08) :1329-1331
[9]   Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia [J].
Ohtsuki, T ;
Sakurai, K ;
Dou, H ;
Toru, M ;
Yamakawa-Kobayashi, K ;
Arinami, T .
MOLECULAR PSYCHIATRY, 2001, 6 (02) :211-216
[10]   The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801 [J].
Rammes, G ;
Mahal, B ;
Putzke, J ;
Parsons, C ;
Spielmanns, P ;
Pestel, E ;
Spanagel, R ;
Zieglgänsberger, W ;
Schadrack, J .
NEUROPHARMACOLOGY, 2001, 40 (06) :749-760